My Top 5 Stock Market Predictions for 2026
It’s that time again… The year 2025 has come to a close, 2026 has begun, and we’re all eager to consider what may lie ahead for stocks in this new year. After a third straight double-digit annual gain, will the S&P 500 continue to roar higher? Which stocks will lead the way? No one can answer those questions with 100% certainty,
» Read more about: My Top 5 Stock Market Predictions for 2026 »
Read MoreHere's When the Federal Reserve Is Expected to Cut Interest Rates in 2026, and What It Means for the Stock Market
History suggests lower interest rates are great for stocks, but there’s an important catch.
The artificial intelligence (AI) boom continued to create trillions of dollars in value for tech and tech-adjacent companies in 2025, which propelled the S&P 500 (^GSPC +0.19%) stock market index to new record highs.
Prediction: This Will Be Microsoft's Stock Price at the End of 2026
Key Points
Microsoft (NASDAQ: MSFT) had a strong 2025, rising from about $420 per share at the start of 2025 to around $490 by December.
» Read more about: Prediction: This Will Be Microsoft's Stock Price at the End of 2026 »
Read MoreUS economy undershoots expectations to add just 50,000 jobs in December
JavaScript is disabled in your browser.
Please enable JavaScript to proceed.
A required part of this site couldn’t load. This may be due to a browser
extension, network issues, or browser settings. Please check your
connection,
» Read more about: US economy undershoots expectations to add just 50,000 jobs in December »
Read MoreThe Burst
1 Bitcoin Miner You Cannot Afford To Miss
Shares of bitcoin miner CleanSpark, Inc. (NASDAQ:CLSK) soared more than bitcoin over the past six months. However, the stock lost its momentum over the past month and declined by more than 11%.
The stock underwent significant volatility due to their correlation with bitcoin’s movement.
» Read more about: 1 Bitcoin Miner You Cannot Afford To Miss »
Read MoreThe Ivy
1 Titan Health Stock Is Way Too Cheap
Merck & Co. (NYSE: MRK) might be best known for its drugs like Keytruda and Gardasil, but those blockbusters haven’t been enough to get shareholders excited as the share price has fallen under water this year, down 6%.
It may well be a pharmaceutical powerhouse but recent price weakness suggests that Merck may be flying under the radar for investors,
» Read more about: 1 Titan Health Stock Is Way Too Cheap »
Read MoreThe Spotlight